Neurocrine Bioscience buy Truist Financial Co.
Start price
30.10.25
/
50%
€119.35
Target price
30.10.26
€148.09
Performance (%)
25.72%
Price
18:02
€150.05
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ currently has a performance of 25.72%. This prediction currently runs until 30.10.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.752% | -3.752% |
| iShares Core DAX® | -0,10 % | 0,54 % |
| iShares Nasdaq 100 | 0,59 % | -2,39 % |
| iShares Nikkei 225® | -0,05 % | -2,75 % |
| iShares S&P 500 | 0,94 % | 1,29 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $172.00 price target on the stock, up previously from $165.00.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€154.55
13.07.26
13.07.26
€175.50
13.07.27
13.07.27
-2.91%
18:02
18:02
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€127.50
07.05.26
07.05.26
€131.84
07.05.27
07.05.27
17.69%
18:02
18:02
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
39.13%
18:02
18:02
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
28.52%
18:02
18:02